Advertisement
U.S. Markets close in 3 hrs 12 mins

Immunic, Inc. (IMUX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
1.2200+0.0400 (+3.39%)
As of 12:48PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close1.1800
Open1.1700
Bid1.2000 x 200
Ask1.2400 x 200
Day's Range1.1700 - 1.2400
52 Week Range0.9450 - 2.1100
Volume846,788
Avg. Volume656,431
Market Cap109.896M
Beta (5Y Monthly)1.88
PE Ratio (TTM)N/A
EPS (TTM)-1.5000
Earnings DateNov 07, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.75
  • Associated Press Finance

    Immunic: Q3 Earnings Snapshot

    NEW YORK (AP) — Immunic, Inc. IMUX) on Thursday reported a loss of $24.4 million in its third quarter. On a per-share basis, the New York-based company said it had a loss of 24 cents.

  • PR Newswire

    Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced financial results for the third quarter and nine months ended September 30, 2024, and provided a corporate update.